Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Lung%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
/vufind/Search/Results?lookfor=%22Lung%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
Search /vufind/Search2/Results?lookfor=%22Lung%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
PubPharm (7.010)
1
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC : A Randomized Trial of Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic (Stage IV) Squamous or Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy : A Phase II, Randomised Study of Nivolumab as Consolidation Therapy in Patients With Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD : A Phase 2a, Open-label, Two-part Study to Evaluate the Mechanism of Action of Itepekimab (Anti-IL-33 mAb) on Airway Inflammation in Patients With Chronic Obstructive Pulmonary Disease (COPD)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy : A Prospective, Single-arm PhaseⅡTrial of Neoadjuvant/Adjuvant Pembrolizumab Plus Platinum-doublet Chemotherapy (Chemo) in IIa-IIIb NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma : A Phase II Study of Osimertinib to Suppress the Progression of Remaining Ground-glass Opacity Nodule (GGN) for Actionable EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Safety and Efficacy of Intravenous Cemiplimab Plus BNT116 Versus Cemiplimab Alone in Advanced Non-Small Cell Lung Cancer in Adult Participants With PD-L1 ≥ 50% : A Phase 2 Study of Cemiplimab (Anti-PD-1 Antibody) in Combination With BNT116 (FixVac Lung) Versus Cemiplimab Monotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With Tumors Expressing PD-L1 ≥50%
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 : A Phase 2 Basket Study of Disitamab Vedotin in Adult Subjects With Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors That Express HER2
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as Small Cell, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile Cancer : A Phase II Study of Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as Small Cell, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER) : A Phase II Study of Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
H01 in Adults With Interstitial Lung Disease (The SOLIS Study) : Phase IIa Investigation of H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[701]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 2
Medienart
7.010
Aufsätze
7.010
E-Artikel
7.010
E-Ressourcen
Zeitschriftentitel
3.800
WHO International Clinical Trials Registry Plat...
3.210
ClinicalTrials.gov
Thema
7.010
610
Phase: Phase 2
6.906
Study Type: Interventional
1.970
Lung Neoplasms
1.838
Carcinoma, Non-Small-Cell Lung
1.830
Recruitment Status: Not yet recruiting
1.277
Recruitment Status: Completed
1.008
Recruitment Status: Recruiting
930
Recruitment Status: Authorised-recruitment may ...
656
Recruitment Status: Complete: follow-up complete
406
Recruitment Status: Terminated
374
Small Cell Lung Carcinoma
348
Lung Diseases
320
Recruitment Status: Active, not recruiting
295
Pulmonary Disease, Chronic Obstructive
282
Recruitment Status: Unknown status
258
Lung Diseases, Obstructive
201
Carcinoma
197
Medical Condition: Lung Cancer
174
Medical Condition: Non-small Cell Lung Cancer
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4.531
2020-
2.380
2010-2019
99
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
6.952
Englisch
24
Unbestimmt
22
Spanisch
10
Französisch
2
Italienisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...